Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response.

We appreciate the comments from the Letter to the Editor authored by Natera (maker of the Signatera MRD test) and collaborating investigators at Aarhus University (Aarhus, Denmark). While we respectfully disagree with the criticisms raised, as detailed below, we believe that this discussion